Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $76.32, with 4.05 million shares of worth about $309.12 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.44% during that period and on Wednesday the price saw a loss of about -0.97%. Currently the company’s common shares owned by public are about 3.10B shares, out of which, 3.10B shares are available for trading.
Stock saw a price change of 0.99% in past 5 days and over the past one month there was a price change of 2.03%. Year-to-date (YTD), AZN shares are showing a performance of 16.48% which increased to 15.10% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $62.75 but also hit the highest price of $87.68 during that period. The average intraday trading volume for Astrazeneca plc ADR shares is 5.55 million. The stock is currently trading 0.21% above its 20-day simple moving average (SMA20), while that difference is up 5.51% for SMA50 and it goes to 1.89% higher than SMA200.
Astrazeneca plc ADR (NASDAQ: AZN) currently have 3.10B outstanding shares and institutions hold larger chunk of about 16.80% of that.
The stock has a current market capitalization of $236.69B and its 3Y-monthly beta is at 0.47. PE ratio of stock for trailing 12 months is 33.87, while it has posted earnings per share of $2.25 in the same period. Its PEG reads 3.06 and has Quick Ratio of 0.74 while making debt-to-equity ratio of 0.74. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AZN, volatility over the week remained 1.09% while standing at 1.27% over the month.
Stock’s fiscal year EPS is expected to rise by 9.18% while it is estimated to increase by 12.89% in next year. EPS is likely to shrink at an annualized rate of 11.08% for next 5-years, compared to annual growth of 34.63% made by the stock over the past 5-years.
Stock get a Sell rating from Deutsche Bank on September 13, 2024.
